Launching product without Approval: DOP rejects Biocon Plea against NPPA action Meghna A Singhania24 Feb 2019 5:55 AM GMTNew Delhi: Through a recent decision, the Department of Pharmaceuticals rejected the review applications filed by biopharmaceutical major Biocon...
Hetero launches generic Lapatinib under the brand name HERTAB in India Farhat Nasim12 Jan 2019 6:44 AM GMTHERTAB (Lapatinib) is an oral therapy indicated for the treatment of postmenopausal women with HER2-positive advanced breast cancer patients whose...
Hetero Labs Limited acquires Tarbis Farma in Spain Medical Dialogues Bureau3 Jan 2019 3:45 AM GMTThe acquisition enables Hetero with a strong front-end marketing presence giving Amarox the required commercial infrastructure, product portfolio,...
Hetero gets DCGI nod to market anti-retroviral FDC tablets Ruby Khatun Khatun17 Nov 2017 5:15 AM GMTNew Delhi: Drug firm Hetero said it has received the Drug Controller General of India's approval to launch generic fixed-dose combination...
